Where it is registered
Each register with its number of medicines and a few of them.
Serbia
ALIMS · 6 medicines
- Ultomiris®100mg/mL · koncentrat za rastvor za infuziju · PredstavniŠTvo Astrazeneca UK Limited Beograd
- Ultomiris®100mg/mL · koncentrat za rastvor za infuziju · PredstavniŠTvo Astrazeneca UK Limited Beograd
- Ultomiris®100mg/mL · koncentrat za rastvor za infuziju · PredstavniŠTvo Astrazeneca UK Limited Beograd
- Ultomiris®100mg/mL · koncentrat za rastvor za infuziju · PredstavniŠTvo Astrazeneca UK Limited Beograd
United States
FDA · 4 medicines
Canada
Health Canada · 3 medicines
Brazil
Anvisa · 2 medicines
All medicines with Ravulizumab
Every register, a page at a time. Strengths and packs are on each medicine’s page.
4 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Ultomiris | United States | 245MG/3.5ML | Injection | Marketed | Alexion Pharmaceuticals, Inc. |
| Ultomiris | United States | 1,100MG/11ML | Injection | Marketed | Alexion Pharmaceuticals, Inc. |
| Ultomiris | United States | 300MG/3ML | Injection | Marketed | Alexion Pharmaceuticals, Inc. |
| Ultomiris | United States | 300MG/30ML | injectable | Marketed | Alexion Pharm |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
- Alexion Europe Sas6 medicines
- Predstavništvo Astrazeneca UK Limited Beograd6 medicines
- Alexion Pharmaceuticals, Inc.4 medicines
- Alexion Pharma GmbH3 medicines
- Alexion Pharma International Operations Unlimited Company1 medicine
- Astrazeneca Singapore Pte Ltd1 medicine
- Alexion Servicos E Farmaceutica Do Brasil Ltda1 medicine
- Astrazeneca Do Brasil Ltda1 medicine
Names in the registers
How the registers write it, in their own languages.
- Ravulizumabe
Sources
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 11
- Medicines
- 24
- Companies
- 8